Accenture, BioCelerate Collaborate on Preclinical Platform

Article

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform allowing its member companies to aggregate and analyze preclinical and clinical information in the hopes of improving drug development efficiency.

Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.